Nevro manufactures implantable neuromodulation and orthopedic devices for chronic pain management. The tech stack reflects a hardware-software hybrid: mobile platforms (iOS, Android, Kotlin Multiplatform) paired with Windows-based clinical programmer software, plus QAD for manufacturing operations. Hiring remains sales-weighted (13 roles) with minimal engineering expansion (5), suggesting a mature product line in sales scaling rather than heavy R&D pivot — consistent with active projects focused on production equipment qualification and manufacturing throughput rather than fundamental platform rewrites.
Notable leadership hires: Sales Director
Nevro is a public medical device company headquartered in Redwood City, California, with 1,001–5,000 employees. The company develops implantable systems for chronic pain relief: the HFX platform (a 10 kHz spinal cord stimulation system and support services) and the Nevro SI Joint system (a minimally invasive SI joint fusion device). Operations span the United States and Costa Rica. Current focus areas include manufacturing scaling, product order fulfillment, and inventory management—typical for a growth-stage medical device manufacturer navigating regulatory compliance, clinical outcomes validation, and supply chain stability.
Nevro's stack includes QAD (enterprise resource planning), Excel, Kotlin Multiplatform, Android, iOS, JUnit, XCTest, GitHub Actions, Windows, and Kotlin. The mix reflects medical device software: mobile apps for patient engagement, Windows-based clinical tools, and Java-ecosystem testing infrastructure.
Nevro operates manufacturing and operations in the United States and Costa Rica. Active projects include acquisition of production equipment and process improvements to reduce manufacturing cycle time and improve throughput.
Other companies in the same industry, closest in size